Novo Nordisk A/S
Novo Nordisk A/S（NVO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nvo · 股价预测 · 39 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 39 位华尔街分析师
Buy
39 位分析师
共识
评级分布
12 个月目标价
High
$54.00
Consensus
$49.50
+15.2% upside
Low
$45.00
Median: $49.5 · Last Close: $42.96
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$49.50
15.2% upside
High Target
$54
25.7%
Low Target
$45
4.7%
Current Price
$42.96
as of today
Based on analyst price targets, the NVO stock price prediction for the next 12 months ranges from $45 to $54. The consensus NVO price forecast of $49.50 implies 15.2% upside from the current price of $42.96.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $41.90 | ↓ 2.46% |
1-day model range: $41.74–$42.06. Peak: $42.06 (-2.46%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $37 | -13.8% |
| 2028 | $34 | -21.6% |
| 2029 | $32 | -26.2% |
| 2030 | $31 | -29.0% |
| 2031 | — | -30.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NVO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-02 | Goldman Sachs | Downgrade ↓ | Buy→Neutral |
| 2026-02-24 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2025-12-08 | Argus Research | Downgrade ↓ | Buy→Hold |
| 2025-11-28 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-11-25 | BMO Capital | Maintains | Market Perform→Market Perform |
| 2025-11-24 | HSBC | Downgrade ↓ | Buy→Hold |
| 2025-10-14 | BMO Capital | Maintains | Market Perform→Market Perform |
| 2025-10-02 | HSBC | Upgrade ↑ | Hold→Buy |
| 2025-09-29 | Morgan Stanley | Downgrade ↓ | Equal Weight→Underweight |
| 2025-09-17 | Berenberg | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on Novo Nordisk A/S (NVO) stock. Of the recent 138 rating actions, 32 were upgrades and 38 were downgrades. 39 analysts currently cover NVO.
分析师推荐趋势
NVO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$295.5B
↓ 8.9% YoY
Revenue Next Year
$302.8B
↑ 2.5% YoY
EPS This Year
$21.82
EPS Next Year
$21.77
↓ 0.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast NVO EPS of $21.82 for the current fiscal year, based on estimates from 8 analysts. The NVO revenue forecast is $295.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NVO 股价预测由两类独立数据源支撑：来自 39 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NVO 的共识目标价为 $49.50（+15.2% 上行空间），分析师共识为 Buy。
NVO 的短期预测（明日）为 $41.90（-2.46%）。 NVO 对 2027 年的股价预测均值为 $37。 NVO 对 2030 年的预测区间为 $29–$32。
Novo Nordisk A/S 在 NYSE 上市，代码 NVO。NVO 在 2027 年的整体展望偏积极，在覆盖分析师中约 59% 对应 Buy 共识。
常见问题
NVO 预测 · 8 个问题根据 39 位华尔街分析师，NVO 的 12 个月平均目标价为 $49.50，最高 $54.00、最低 $45.00。若有图表，中位目标价可在上方查看。相对当前价 $42.96，隐含约 +15.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.